Research advances in sorafenib-induced apoptotic signaling pathways in liver cancer cells

Research advances in sorafenib-induced apoptotic signaling pathways in liver cancer cells

Currently, sorafenib is the multi-target inhibitor for the treatment of advanced primary liver cancer, and can effectively prolong the progression-free survival and overall survival in patients with advanced primary liver cancer. The application of sorafenib in the targeted therapy for liver cancer...

Full description

Bibliographic Details
Main Authors:	ZHANG Chaoya, ZHAO Xiangxuan, LU Zaiming
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2016-04-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=7326

Similar Items

Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
by: Hongbo Wang, et al.
Published: (2019-12-01)

Research advances in the role of aquaporins in liver fibrosis and liver cirrhosis
by: ZHAO Xiangxuan, et al.
Published: (2016-06-01)

The role of MAPK signaling pathway in development/progression and treatment of liver cancer
by: CIDAN Wangjiu, et al.
Published: (2016-09-01)

Foeniculum vulgare seed extract induces apoptosis in lung cancer cells partly through the down-regulation of Bcl-2
by: Weiwei Ke, et al.
Published: (2021-03-01)

Unusual apoptotic signaling pathways in cancer cells induced by cephalostatin
by: Rudy, Anita
Published: (2007)

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.
by: Melchiorre Cervello, et al.
Published: (2013-01-01)

Complete response for advanced liver cancer during sorafenib therapy: Case Report
by: Romano Antonio, et al.
Published: (2011-01-01)

Role of cell apoptosis regulated by P53 in treatment of hepatocellular carcinoma
by: GAO Si, et al.
Published: (2017-07-01)

The potential roles of exosomes in pancreatic cancer initiation and metastasis
by: Wei Sun, et al.
Published: (2020-09-01)

Research advances in the sphingosine kinase signaling pathway in liver fibrosis
by: SUN Yue, et al.
Published: (2017-09-01)

m6A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma
by: Hongbo Wang, et al.
Published: (2021-02-01)

IL-2 augments the sorafenib-induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
by: Xiaoyan Ding, et al.
Published: (2018-11-01)

Role Of S-Nitrosylation In The Extrinsic Apoptotic Signalling Pathway In Cancer
by: Stéphanie Plenchette
Published: (2015-08-01)

Research advances in sorafenib combined with orthotopic liver transplantation, radiofrequency ablation, and transarterial chemoembolization in treatment of hepatocellular carcinoma
by: ZHANG Mingjuan
Published: (2014-08-01)

Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma
by: WU Lei, et al.
Published: (2018-04-01)

Advances of Liver X Receptor Signaling Pathways in Prostate Cancer
by: Yun LIU, et al.
Published: (2016-12-01)

RETRACTED: Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cellby inducing mitochondrial fragmentation and activating MAPK-JNKsignalling pathway
by: Lijuan Zhang, et al.
Published: (2019-02-01)

Research advances in signaling pathways involved in liver regeneration mediated by oval cells
by: ZHONG Xiaomao, et al.
Published: (2016-12-01)

Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
by: Xiaoyan Ding, et al.
Published: (2019-12-01)

Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy
by: Haiwei Ye, et al.
Published: (2020-01-01)

Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
by: Jie Song, et al.
Published: (2019-12-01)

RETRACTED ARTICLE: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK–Mfn2 signaling pathway
by: Jie Song, et al.
Published: (2019-03-01)

Clinical experience in using sorafenib in patients with advanced kidney cancer
by: A. V. Zyryanov, et al.
Published: (2017-06-01)

Sorafenib-Induced Liver Failure: A Case Report and Review of the Literature
by: Anneleen Van Hootegem, et al.
Published: (2011-01-01)

Research Advances of JAK/STAT Signaling Pathway in Lung Cancer
by: Xin YANG, et al.
Published: (2019-01-01)

Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01)

Sorafenib for the treatment of advanced hepatocellular carcinoma
by: M Connock, et al.
Published: (2010-05-01)

Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications
by: Silvia Anahi Valdés-Rives, et al.
Published: (2017-01-01)

Cytoplasmic vacuolation with endoplasmic reticulum stress directs sorafenib induced non-apoptotic cell death in hepatic stellate cells
by: Sachin Sharma, et al.
Published: (2021-02-01)

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
by: Yang Zhao, et al.
Published: (2019-05-01)

The Drug Resistance Mechanism of Liver Cancer Stem Cells in Sorafenib Treatment
by: LIAO, CHEN-CHUN, et al.
Published: (2018)

Retraction notice to “Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway” [Biomed. Pharmacother. 110 (2019) 213–223]
by: Lijuan Zhang, et al.
Published: (2020-09-01)

Role of pyruvate kinase muscle isozyme 2 in pathogenesis and diagnosis of liver cancer
by: CIDAN Wangjiu, et al.
Published: (2016-04-01)

Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells.
by: Mariela Rivera, et al.
Published: (2017-01-01)

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
by: Yoo EJ, et al.
Published: (2013-06-01)

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
by: Hidenari Nagai, et al.
Published: (2012-01-01)

Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.
by: Sangheun Lee, et al.
Published: (2013-01-01)

The apoptotic signal transduction pathways induced by single-wallcarbon nanotube in human lung cells
by: Jui-Liang Hou, et al.

Non-Apoptotic Cell Death Signaling Pathways in Melanoma
by: Mariusz L. Hartman
Published: (2020-04-01)

Apoptotic signaling pathways in mammalian growth plate chondrocytes
by: Zhong, Ming
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4va1qe0scnt5egjhv6i74qt1pm